Iisrael - heebrea - Ministry of Health

dexcel ltd, israel - isosorbide mononitrate - טבליה - isosorbide mononitrate 40 mg - isosorbide mononitrate - isosorbide mononitrate - for the treatment of angina pectoris and prevention of anginal attacks, treatment of congestive heart failure.

Iisrael - heebrea - Ministry of Health

dexcel ltd, israel - isosorbide mononitrate - טבליה - isosorbide mononitrate 20 mg - isosorbide mononitrate - isosorbide mononitrate - for the treatment of angina pectoris and prevention of anginal attacks. treatment of congestive heart failure.

Iisrael - heebrea - Ministry of Health

rafa laboratories ltd - phenoxybenzamine hydrochloride - קפסולות - phenoxybenzamine hydrochloride 10 mg - phenoxybenzamine - phenoxybenzamine - pheochromocytoma, benign prostatic hypertrophy.

Iisrael - heebrea - Ministry of Health

padagis israel pharmaceuticals ltd, israel - diclofenac sodium - ג'ל - diclofenac sodium 3 % - diclofenac - diclofenac - for the treatment of actinic keratoses

Iisrael - heebrea - Ministry of Health

salomon,levin & elstein ltd - cloxacillin as sodium - אבקה להכנת תמיסה לזריקה - cloxacillin as sodium 2 g/vial - cloxacillin - cloxacillin - for the treatment of infections caused by penicillinase-producing staphylococci. because of the high incidence of staphylococcal isolates resistant to penicillin g both within and outside the hospiral environment . orbenil is recommended as initial therapy in patients with suspected staphylococcal infections. orebenil is also effective in the treatment of other commonly encountered gram-positive coccal infections.typical indications include: - respiratory tract infections such as pneumonia and sinusitis - infected wounds and burns - osteomyelitis and septic arthritis - other infections due to staphylococci (including penicillin-resistant strains) such as septicemia endocarditis enterocolitis and urinary tract infections.

Iisrael - heebrea - Ministry of Health

rekah pharmaceutical industry ltd, israel - sulphamethoxazole; trimethoprim - תרחיף - sulphamethoxazole 4 %; trimethoprim 0.8 % - sulfamethoxazole and trimethoprim - sulfamethoxazole and trimethoprim - antibacterial for treatment of infections due to susceptible micro-organisms in the upper and lower respiratory tract infections, urinary tract infections, gastro-intestinal tract infections.

Iisrael - heebrea - Ministry of Health

rekah pharmaceutical industry ltd, israel - sulphamethoxazole; trimethoprim - קפליות - trimethoprim 160 mg; sulphamethoxazole 800 mg - sulfamethoxazole and trimethoprim - sulfamethoxazole and trimethoprim - antibacterial treatment in infections due to susceptible microorganisms in urinary, respiratory and gastro-intestinal tract or genital system infections.

Iisrael - heebrea - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

Iisrael - heebrea - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

Iisrael - heebrea - Ministry of Health

cts chemical industries ltd, israel - potassium clorazepate - קפסולות - potassium clorazepate 5 mg - potassium clorazepate - potassium clorazepate - for the management and relief of anxiety, symptomatic relief of acute alcohol withdrawal, adjunctive therapy in the management of partial seizures.